Levetiracetam in the Treatment of Neuropathic Pain: Three Case Studies

Clinical Journal of Pain

Volumn 20, Issue 1, 2004, Pages 33-36

  Price, Michael J ^a,b,c  

^a Wuesthoff Hospital   (United States)

^b Health First   (United States)

^c NONE   (United States)

Author keywords

Levetiracetam; Neuropathic pain; Peripheral neuropathy

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; ETIRACETAM; GABAPENTIN; NORTRIPTYLINE; PIRACETAM; THIAMINE; TOPIRAMATE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CASE REPORT; CONFUSION; CONSTIPATION; DROWSINESS; DRUG EFFICACY; FEMALE; HUMAN; LEG PAIN; MALE; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROPATHIC PAIN; ORAL DRUG ADMINISTRATION; PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTICONVULSANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; PIRACETAM; TREATMENT OUTCOME;

EID: 0346965908     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200401000-00007     Document Type: Article

References (22)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-1964.
2. Backonja MM. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain. 2000;16(suppl 2):S67-S72.
3. Bennett GJ. Neuropathic pain: new insights, new interventions. Hosp Pract. 1998;33:95-114.
4. Hansen HC. Treatment of chronic pain with antiepileptic drugs: a new era. South Med J. 1999;92:642-649.
5. McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311:1047-1052.
6. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 1997;73:123-139.
7. Harden C. Safety profile of levetiracetam. Epilepsia. 2001;42(suppl 4):36-39.
8. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85:77-85.
9. Browne TR, Szabo GK, Leppik IE, et al. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique. J Clin Pharmacol. 2000;40:590-595.
10. Keppra™ tablets [Physician's Desk Reference® electronic library Web site]. Available at: http://www.pdrel.com/pdr/static.htm?path= pdrel/pdr/82560130.htm. Accessed October 15, 2001.
11. Laird MA, Gidal BE. Use of gabapentin in the treatment of neuropathic pain. Ann Pharmacother. 2000;34:802-807.
12. Ollat H, Cesaro P. Pharmacology of neuropathic pain. Clin Neuropharmacol. 1995;18:391-404.
13. Loscher W, Honack D. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam. Epilepsia. 2000;41:1499-1506.
14. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389-400.
15. Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs. 2000;59:1113-1126.
16. Covington EC. Anticonvulsants for neuropathic pain and detoxification. Clev Clin J Med. 1998;65(suppl 1):S121-S129.
17. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
18. Margineanu DG, Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res. 2000;42:281-285.
19. Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia. 2001;42(suppl 4):13-18.
20. Shorvon SD, Lowenthal A, Janz D, et al. Multicenter, double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia. 2000;41:1179-1186.
21. Privitera M. Efficacy of levetiracetam: a review of three pivotal clinical trials. Epilepsia. 2001;42(suppl 4):31-35.
22. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia. 2000;41:1276-1283.